AR

Akshay Raj Saxena

Active Director Director DIN 10770497
DIN 10770497 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Akshay Raj Saxena

Data last updated:

Akshay Raj Saxena is a Director at Mont Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Mont Pharmaceuticals Private Limited reported revenue of ₹64,828 (FY 2025).

DIN 10770497
Primary Designation Director
Industry Pharma
First Appointment 18 Oct 2024
Oldest Company Age 2 yrs
Largest company Mont Pharmaceuticals Private Limited · ₹64,828 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mont Pharmaceuticals Private Limited U47721DL2024PTC437901
Director18 Oct 20242024₹64,828 (FY 2025)Active

Board colleagues of Akshay Raj Saxena

NameDINCompanyDesignation
Sunil Kumar Saxena10771540Mont Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mont Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akshay Raj Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Raj Saxena

Akshay Raj Saxena currently holds 1 directorship: Mont Pharmaceuticals Private Limited (Director, since 18 Oct 2024, revenue ₹64,828 (FY 2025)).

Akshay Raj Saxena was first appointed on 18 Oct 2024 as Director at Mont Pharmaceuticals Private Limited.

The current boards of Akshay Raj Saxena's companies include Sunil Kumar Saxena (Mont Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available